Press Releases

Onkos Surgical Announces Definitive Agreement to Acquire the JTS Extendible Prosthesis

Company expands musculoskeletal oncology portfolio with device to treat pediatric bone cancer PARSIPPANY, N.J., June 13, 2022 /PRNewswire/ — Onkos Surgical, Inc., a rapidly growing, leading innovator of solutions for musculoskeletal oncology and complex orthopaedic conditions, announced today that it has entered into a definitive agreement with Stryker to acquire the...

Learn More

Onkos Surgical^® raises $15 million in series c funding

Funds will accelerate innovation, expand commercial presence, and drive manufacturing improvements in surgical solutions for musculoskeletal oncology and complex orthopaedicsPARSIPPANY, N.J., Sept. 1, 2021— Onkos Surgical, a leading innovator of solutions for musculoskeletal oncology and complex orthopaedic procedures, today announced that it has raised $15 million in Series C funding...

Learn More

Onkos Surgical^® announces FDA 510(k) clearance of its BioGrip^® modular porous collars, a first-of-its-kind solution to help address implant loosening in orthopaedic oncology and complex revision surgery

The new offering, available as part of the ELEOS™ Limb Salvage System, is designed to help support bone ingrowth in musculoskeletal oncology and complex orthopaedic limb salvage cases with a novel 3D-printed porous designPARSIPPANY, N.J., June 22, 2021— Onkos Surgical, a leading innovator of solutions for musculoskeletal oncology and complex...

Learn More

Onkos Surgical^® celebrates patient experience week with focus on patient-centered innovation

PARSIPPANY, N.J., April 29, 2021 — In celebration of Patient Experience Week (April 26-30, 2021), Onkos Surgical, a leading innovator of solutions for musculoskeletal oncology and complex orthopaedic procedures, today announced ongoing growth and adoption of its patient-centric innovations. These solutions are designed to help improve patient outcomes and experiences using...

Learn More

Onkos Surgical^® continues its innovation in musculoskeletal oncology and complex orthopaedic reconstruction with the launch of the ELEOS^™ Proximal Tibia with BioGrip^™ technology

PARSIPPANY, N.J., December 21, 2020 –  Onkos Surgical, Inc., an innovator in the field of musculoskeletal oncology and personalized orthopaedics, continues to deliver on its promise of commercializing innovative solutions with the launch of the new ELEOS Proximal Tibia with BioGrip technology. The product, used in complex tumor and orthopaedic...

Learn More

Business Update Regarding COVID-19

March 27, 2020 – We recognize that our customers, patients, caregivers, and partners have a great deal of information coming from all directions during this rapidly changing time. This memorandum is a brief update regarding what Onkos Surgical is doing to ensure business continuity. First, on behalf of everyone at Onkos,...

Learn More

Onkos Surgical^® to Launch New Personalized Surgery Platform with Disruptive Service Model for Joint Sparing Tumor Surgery

PARSIPPANY, N.J., September 26, 2019 – Onkos Surgical, Inc. announced today the launch of My3D™ Personalized Solutions powered by 3D Systems VSP® (Virtual Surgical Planning) Orthopaedics. The launch of this platform is the first of several products to be released under the companies’ previously announced collaboration to advance personalized solutions...

Learn More

Onkos Surgical^® and Insight Medical Systems Team Up to Explore Applications of Augmented Reality in Musculoskeletal Oncology

PARSIPPANY, N.J., July 9, 2018 – Insight Medical Systems (Laguna Hills, CA) has teamed up with Onkos Surgical, Inc. (Parsippany, NJ) to explore opportunities to apply Insight Medical’s ARVIS™ (Augmented Reality Visualization and Information System) in musculoskeletal oncology. The companies are working on a pilot project to assess the technology for...

Learn More

ONKOS SURGICAL’s 3rd annual partnership with MSTS kicks off at the AAOS annual meeting in New Orleans

Onkos Surgical® has renewed our diamond level sponsorship with the MSTS for 2018. This marks the second year of our partnership with the society. Onkos continues to focus our innovation initiatives in three areas: 1) infection management, 2) aseptic loosening and 3) soft tissue management. Our sponsorship of the MSTS is...

Learn More

Onkos Surgical^® and 3D Systems Team to Advance Personalized Surgical Oncology Solutions

PARSIPPANY, N.J., March 6, 2018 – Onkos Surgical, Inc. announced today that it signed a 4-year agreement with 3D Systems (NYSE: DDD) to advance the delivery of personalized surgical solutions and help improve patient outcomes. The agreement provides Onkos Surgical priority access to 3D Systems’ VSP® (Virtual Surgical Planning) Orthopedic...

Learn More